The COVID-19 pandemic and colorectal cancer prevention: God tempers the wind to the shorn lamb
- PMID: 32967017
- PMCID: PMC7516359
- DOI: 10.1055/a-1243-1372
The COVID-19 pandemic and colorectal cancer prevention: God tempers the wind to the shorn lamb
Conflict of interest statement
M. Pellisé has received consultancy and speaker’s fees from Norgine Iberia (2015–2019), a consultancy fee from GI Supply (2019), speaker’s fees from Casen Recordati (2016–2019), Olympus (2018), and Jansen (2018), and research funding from Fujifilm Spain (2019), Fujifilm Europe (2020), and Casen Recordati (2020); her department has received loan material from Fujifilm Spain (from 2017 ongoing), a research grant from Olympus Europe (2005–2019), and loan material and a research grant from Fujifilm Europe (2020–2021); she is a Board member of ESGE and SEED; and receives a fee from Thieme as an Endoscopy Co-Editor.
Comment on
-
Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer.Endoscopy. 2020 Oct;52(10):871-876. doi: 10.1055/a-1159-0644. Epub 2020 Apr 30. Endoscopy. 2020. PMID: 32356282
References
-
- Moss S, Ancelle-Park R, Brenner H et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition – evaluation and interpretation of screening outcomes. Endoscopy. 2012;44 03:SE49–SE64. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
